TDACU Stock Price, Chart, Stats & News

Translational Development Acquisition Corp.
Save
Translational Development Acquisition Corp. (TDACU) does not currently pay a dividend.
248.83M
Market cap
–
Current P/E
–
Forward P/E
TDACU chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 4.20% |
Operating margin | -165.48% |
Pretax margin | 860.04% |
Net margin | 860.04% |
Effective tax rate | – |
ROA | 2.64% |
ROE | 2.78% |
D/E | 0.00x |
Interest coverage ratio | 15.23x |
TDACU valuation
P/E | – |
P/S | 418.91x |
P/B | 1.05x |
P/CF | -74.24x |
P/FCF | -94.28x |
P/OCF | -74.24x |
PEG | 1.83x |
EV multiple | -252.63x |
About
Translational Development Acquisition Corp. (TDACU) functions as a blank check entity, currently lacking any operational businesses or ventures of its own. Its sole purpose is to identify and complete a significant business combination, which could take the form of a merger, acquisition, asset purchase, share exchange, recapitalization, or other similar transaction with an existing company or companies. TDACU's strategic focus for this combination is specifically directed towards enterprises engaged in the oil, gas, or broader natural resources industries located within Eastern Europe.
Similar securities
Based on sector and market capitalization
Report issue











